Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

LEMAITRE VASCULAR, INC.

(LMAT)
  Report
Delayed Nasdaq  -  04:00:01 2023-01-27 pm EST
45.88 USD   -0.15%
2022LeMaitre to Present at Upcoming Investor Conferences
AQ
2022LEMAITRE VASCULAR, INC. : Ex-dividend day for
FA
2022LEMAITRE VASCULAR INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Analyst Recommendations on LEMAITRE VASCULAR, INC.
2022Barrington Research Downgrades LeMaitre Vascular to Market Perform From Outperform
MT
2022Barrington Lowers LeMaitre Vascular's Price Target to $50 From $54, Maintains Outperfor..
MT
2022Barrington Research Trims LeMaitre Vascular's Price Target to $54 From $62, Maintains O..
MT
2021Barrington Adjusts Price Target on LeMaitre Vascular to $62 From $64, Maintains Outperf..
MT
2021LeMaitre Vascular : Jefferies Initiates LeMaitre Vascular at Buy Ratin..
MT
2021LeMaitre Vascular : Roth Capital Adjusts LeMaitre Vascular's Price Tar..
MT
2021LeMaitre Vascular : Barrington Adjusts Price Target on LeMaitre Vascul..
MT
2021LeMaitre Vascular : Roth Capital Adjusts LeMaitre Vascular PT to $55 F..
MT
2021LeMaitre Vascular : Barrington Adjusts Price Target on LeMaitre Vascul..
MT
2021LeMaitre Vascular : Barrington Adjusts LeMaitre Vascular PT to $49 Fro..
MT
2021LeMaitre Vascular : KeyBanc Starts LeMaitre Vascular at Sector Weight
MT
2020LeMaitre Vascular : Barrington Research Adjusts Price Target on LeMait..
MT
2020LeMaitre Vascular : Roth Capital Adjusts LeMaitre Vascular PT to $36 F..
MT
Upcoming event on LEMAITRE VASCULAR, INC.